Amazon cover image
Image from Amazon.com

Disposable bioprocessing systems / Sarfaraz K. Niazi.

By: Material type: TextTextPublisher: Boca Raton, Fla. : CRC Press, 2012Description: 1 online resource (xxi, 300 pages) : illustrationsContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781439866955
  • 1439866953
  • 1280122579
  • 9781280122576
  • 0429104960
  • 9780429104961
  • 9786613526434
  • 6613526436
Subject(s): Genre/Form: Additional physical formats: Print version:: No titleDDC classification:
  • 660.6 N577
LOC classification:
  • TP248.2 .N53 2012
Online resources:
Contents:
1. The bioprocessing industry : an introduction -- 2. Safety of disposable systems -- 3. Containers -- 4. Mixing systems -- 5. Disposable bioreactors -- 6. Connectors and transfers -- 7. Controls -- 8. Downstream processing -- 9. Filling and finishing systems -- 10. Filtration -- 11. Regulatory compliance -- 12. Environmental concerns -- 13. Epilogue.
Summary: Because of many misconceptions, the biological drug manufacturing industry does not fully utilize disposable components, despite their wide availability. These misconceptions include concerns for the quality of materials, running costs, scalability, the level of automation possible, and the training of staff needed to include these components in existing bioprocessing systems. Not fully realizing the long-term benefits, many manufacturers are unwilling to discard investments made in fixed equipment and traditional stainless steel systems. Regulatory and environmental concerns, however, will ev.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Includes bibliographical references (pages 253-290) and index.

1. The bioprocessing industry : an introduction -- 2. Safety of disposable systems -- 3. Containers -- 4. Mixing systems -- 5. Disposable bioreactors -- 6. Connectors and transfers -- 7. Controls -- 8. Downstream processing -- 9. Filling and finishing systems -- 10. Filtration -- 11. Regulatory compliance -- 12. Environmental concerns -- 13. Epilogue.

Because of many misconceptions, the biological drug manufacturing industry does not fully utilize disposable components, despite their wide availability. These misconceptions include concerns for the quality of materials, running costs, scalability, the level of automation possible, and the training of staff needed to include these components in existing bioprocessing systems. Not fully realizing the long-term benefits, many manufacturers are unwilling to discard investments made in fixed equipment and traditional stainless steel systems. Regulatory and environmental concerns, however, will ev.

English.

Open Access EbpS

There are no comments on this title.

to post a comment.